You are here

CDC: Two Out of Three People With Invasive Cancer Are Surviving 5 Years or More

Prostate is most common cancer site, report finds

Two out of three people diagnosed with cancer survive 5 years or more, according to a study from the Centers for Disease Control and Prevention (CDC) published March 13 in the Morbidity and Mortality Weekly Report.

The study found that the most common cancer sites continue to be cancers of the prostate (128 cases per 100,000 men), the female breast (122 cases per 100,000 women), the lung and bronchus (61 cases per 100,000 persons), and the colon and rectum (40 cases per 100,000 persons). Among these common cancer sites, the 5-year relative survival rate was 97% for prostate cancer, 88% for breast cancer, 63% for colorectal cancer, and 18% for lung cancer.

The cancer survival estimates are from CDC’s National Program of Cancer Registries. CDC scientists reviewed the most recent data on cases of invasive cancers reported during 2011. With the exception of urinary bladder cancer, invasive cancer is defined as cancer that has spread to surrounding normal tissue from where it began.

The authors noted that disparities in cancer incidences still persist, with greater rates among men than women and the highest rates among blacks. In addition, 5-year relative survival after any cancer diagnosis was slightly lower for blacks (60%) than for whites (65%).

Data by state show incidence rates for all cancer sites ranged from 374 cases per 100,000 persons in New Mexico to 509 cases per 100,000 persons in the District of Columbia.

“These data are an important reminder that a key to surviving with cancer is making sure everyone has access to care from early diagnosis to treatment,” said Lisa Richardson, MD, director of the CDC’s Division of Cancer Prevention and Control. “We know, for example, that early detection of colorectal cancer has had the largest impact on long-term survival rates.”

Sources: CDC; March 12, 2015; and MMWR; March 13, 2015.


More Headlines

Liver Fluke Infestation Affects Almost 2.5 Million People Globally
Policy Could Be Life-Changing for People With Spinal Cord Injury
Test Determines Severity of Pain, Helps Physicians Select Best Options
Intratumoral Injection Stimulates Immune Activation
Diabetes and Cancer Patients Could Soon Avoid Injections
Early Cancer Development May Begin in Just 30 Minutes
In Most Cases, Plaque/Tangle Dissolution Occurred Almost Instantly